Immunocytokine with target cell-restricted IL-15 activity for treatment of acute lymphoblastic leukemia (ALL)

被引：0
作者：
Hagelstein, I [1 ,2 ]
Zekri, L. [1 ,2 ]
Klimovich, B. [1 ,2 ]
Lutz, M. S. [1 ,2 ]
Greve, C. [3 ]
Maerklin, M. [1 ,2 ]
Mueller, S. [1 ,2 ]
Schmied, B. J. [1 ,2 ]
Jung, G. [3 ]
Salih, H. R. [1 ,2 ]
机构：
[1] Univ Hosp Tubingen, Dept Internal Med, German Canc Consortium DKTK, Clin Collaborat Unit Translat Immunol, Tubingen, Germany
[2] Univ Tubingen, Cluster Excellence iFIT EXC2180 Image Guided & Fu, Tubingen, Germany
[3] Eberhard Karls Univ Tubingen, Dept Immunol, Tubingen, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2021年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V281
引用
收藏
页码：36 / 36
页数：1
相关论文
共 50 条
  • [41] INTERLEUKIN-15 (IL-15) ADMINISTRATION INCREASES GRAFT VERSUS LEUKEMIA ACTIVITY IN RECIPIENTS OF HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Sauter, C.
    Bailey, C.
    Biswas, C.
    Budak, T.
    Panis, M.
    Alpdogan, O.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S358 - S358
  • [42] The IL-15/IL-15Rα on cell surfaces enables sustained IL-15 activity and contributes to the long survival of CD8 memory T cells
    Sato, Noriko
    Patel, Hirai J.
    Waldmann, Thomas A.
    Tagaya, Yutaka
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (02) : 588 - 593
  • [43] IMMUNOPHENOTYPE AND PROLIFERATIVE ACTIVITY OF CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)
    BENJAMIN, DR
    LABORATORY INVESTIGATION, 1992, 66 (01) : P2 - P2
  • [44] SERUM SOMATOMEDIN ACTIVITY (SMACT) IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
    PRICE, DA
    SHALET, SM
    BEARDWELL, CG
    HANN, IM
    JONES, PHM
    PEDIATRIC RESEARCH, 1978, 12 (02) : 159 - 159
  • [45] Low expression of IL-15 in adult B-lineage acute lymphoblastic leukemia is associated with central nervous system involvement at initial presentation
    Wu, Shuling
    Burmeister, Thomas
    Baldus, Claudia
    Schwartz, Stefen
    Notter, Michael
    Goekbuget, Nicola
    Hoelzer, Dicter
    Hofmann, Wolf K.
    Thiel, Eckhard
    BLOOD, 2007, 110 (11) : 705A - 706A
  • [46] T-cell priming with Deep IL-15 improves preclinical safety compared to systemic IL-15, and increases in vivo persistence and activity
    Geretti, Elena
    Bardwell, Philip
    Liang, Xiaoyan
    Caruso, Santina
    Chang, De-Kuan
    Lyons, Jesse
    Boesch, Austin
    Handler, Aaron
    Tassa, Carlos
    Bilic, Sanela
    Lancita, Janice
    Hawes, Becker
    Fitzgerald, Jonathan
    Andresen, Thomas
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [47] Interleukin-15 (IL-15) can replace the IL-2 signal in IL-2-dependent adult T-cell leukemia (ATL) cell lines:: Expression of IL-15 receptor α on ATL cells
    Yamada, Y
    Sugawara, K
    Hata, T
    Tsuruta, K
    Moriuchi, R
    Maeda, T
    Atogami, S
    Murata, K
    Fujimoto, K
    Kohno, T
    Tsukasaki, K
    Tomonaga, M
    Hirakata, Y
    Kamihira, S
    BLOOD, 1998, 91 (11) : 4265 - 4272
  • [48] Influence of intensive maintenance on the treatment of adult acute lymphoblastic leukemia (ALL).
    Lopez-Hernandez, MA
    DeDiego, JE
    Alvarado, M
    Gonzalez-Avante, M
    Trueba, E
    Borbolla, JR
    Jimenez, JR
    Mendoza, Y
    BLOOD, 2000, 96 (11) : 213B - 213B
  • [49] Notch, a unifying target in T-cell acute lymphoblastic leukemia?
    Screpanti, I
    Bellavia, D
    Campese, AF
    Frati, L
    Gulino, A
    TRENDS IN MOLECULAR MEDICINE, 2003, 9 (01) : 30 - 35
  • [50] HRQOL implications of treatment with dexamethasone for children with acute lymphoblastic leukemia (ALL)
    Eiser, C
    Davies, H
    Jenney, M
    Stride, C
    Glaser, A
    PEDIATRIC BLOOD & CANCER, 2006, 46 (01) : 35 - 39
12345